Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07659886 · ClinicalTrials.gov registry record · Phase 3
Implementation of Vancomycin Powder Application in the Emergency Department for Open Fractures
A Phase 3 study, sponsored by Atlantic Health System.
- Not yet
- Registry status
- Phase 3
- Development phase
- 100
- Enrollment target
NCT07659886: Clinical Trial Phase 3 study, sponsored by Atlantic Health System.
NCT07659886 is a Phase 3 study that has not yet begun recruiting, run by Atlantic Health System. The registered enrollment target is 100 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (87% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07659886, a Phase 3 study, has not yet begun recruiting, sponsored by Atlantic Health System.
- NOT YET RECRUITING
- Registry status
- Phase 3
- Development phase
- 100 participants
- Enrollment target
Study Summary
To evaluate the feasibility, safety, and potential efficacy of applying vancomycin powder locally to open fractures in the emergency department prior to definitive surgical intervention.
Primary Outcome
Incidence of deep surgical site infection following open fracture treatment, defined according to Centers for Disease Control and Prevention (CDC)/National Healthcare Safety Network (NHSN) criteria and/or requiring operative irrigation and debridement or deep culture-directed antibiotic treatment.
Interventions
- DRUG Vancomycin (VAN) treatment
- OTHER Standard Open Fracture Care
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2026-06-10 |
| Est. Completion | 2027-06-10 |
| Phase | Phase 3 |
What is known before NCT07659886 opens enrollment
NCT07659886 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (87% lower).
The record links to 0 conditions, and to 2 interventions - of which Vancomycin (VAN) treatment is the first listed.
NCT07659886 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07659886 about?
NCT07659886 is a clinical study titled "Implementation of Vancomycin Powder Application in the Emergency Department for Open Fractures". To evaluate the feasibility, safety, and potential efficacy of applying vancomycin powder locally to open fractures in the emergency department prior to definitive surgical intervention.
What is the current status of trial NCT07659886?
This trial is currently not yet recruiting. It is a Phase 3 study. The enrollment target is 100 participants. The study started on 2026-06-10. Estimated completion is 2027-06-10.
What interventions are being tested in trial NCT07659886?
The interventions under investigation include: Vancomycin (VAN) treatment (DRUG), Standard Open Fracture Care (OTHER).
Who is sponsoring clinical trial NCT07659886?
This trial is sponsored by Atlantic Health System, which has 43 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07659886's enrollment target sits among peer trials
100 1681st of 2000 higher than 288 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI